Hello, Thanks for signing up for MarketBeat Daily Ratings—we’re excited to have you on board. Every weekday, you’ll get a curated summary of new “Buy” and “Sell” ratings from Wall Street’s top-rated analysts, the latest stock news, and bonus investing content—all delivered straight to your inbox. You’re just two quick steps away from completing your sign-up: 1. Make sure our emails go to your inboxGmail users:
Mobile: Tap the three dots (…) in the top right and select Move to Inbox or Move to Primary
Desktop: Click the folder icon at the top and select Move to Inbox or Primary Apple Mail users:
Tap our email address at the top (next to From: on mobile), then select Add to VIP Other providers:
Reply to this message and add newsletters@analystratings.net to your contacts 2. Confirm your subscriptionClick this link to confirm your subscription. This verifies your account and ensures you receive your newsletters without interruption instead of getting stuck in your spam filter. Confirm your subscription here. After you confirm, feel free to download our popular free report, "7 Stocks to Buy and Hold Forever" with this link. Thanks again for subscribing—we look forward to being part of your investing journey. 
Matthew Paulson
Founder and CEO, MarketBeat. P.S. If you didn’t mean to subscribe, no problem—you can unsubscribe here.
More Reading from MarketBeat
Sell-Side Support Lifts RTX in 2026: 20% Upside IndicatedBy Thomas Hughes. Publication Date: 4/22/2026. 
Key Points
- RTX pulled back following the Q1 release, with tepid guidance that forecast growth and margin strength.
- Analysts and institutions are accumulating this stock.
- New contracts and a growing backlog suggest outperformance is likely in upcoming quarters.
- Special Report: Elon Musk: This Could Turn $100 into $100,000
RTX (NYSE: RTX) faces some headwinds and hurdles in 2026, but analysts, institutional support, and demand for its products are not among them. The primary headwind — more of a missing tailwind — is the pause in buyback activity following a January 2026 executive order from President Trump restricting share repurchases and dividends at defense contractors identified as underperforming on military contracts. RTX was specifically named in connection with the order. That pause has led to a slight increase in share count, but the change is modest relative to the company’s business growth, balance-sheet health, and capacity to maintain dividend payments.
SpaceX is already one of the most valuable private companies on Earth, and some analysts believe its valuation could reach over $1.5 trillion. But since SpaceX isn't publicly traded, most investors assume they have no way to invest—that assumption may be wrong.
According to veteran investor Matt McCall, there's a little-known public investment vehicle that provides exposure to SpaceX and dozens of other private companies, and today shares trade for less than $30. Click here to see the full story
Dividends remain on the table, yielding about 1.4% with shares near April 2026 highs. The payout is modest relative to the broader market, but the financial metrics point to reliability and the potential for increases over time. The payout ratio sits just above 50% of earnings, earnings are growing, and the company has a history of five consecutive annual dividend hikes and a high single-digit compound annual growth rate. The chief investor risk is that RTX either falls behind schedule or exceeds budget on defense contracts, which could invite regulatory scrutiny. Bullish Analyst Trends Support RTX Stock Price AdvanceRTX’s analyst trends are not wildly bullish but reflect a solid support base accumulating shares. The 22 analysts tracked by MarketBeat rate the stock a Moderate Buy. Coverage and price targets have been rising. In late April the consensus implied roughly 8% upside, while more recent updates point toward the high end of the range. Those updates would place the stock near $240 — about 20% above critical support — and the upward trend appears set to continue. Although the company’s guidance fell short of consensus, it still reflects a healthy trajectory, strong free cash flow, and a generally cautious posture. Institutional activity is similarly bullish. Institutions own about 87% of the stock and have been aggressive buyers in 2026, purchasing at roughly a $2-to-$1 pace in Q1 and accelerating into early Q2. That continued accumulation should limit downside risk while the market finds direction. As of now, key support sits near the 2026 lows around $190. Short interest is not a significant factor, having fallen from its 2024 peak to about 1%. RTX Stock Price Sets Up for Its Next Big MoveRTX’s price action shows the potential for further downside after a market top, so a deeper sell-off remains a risk. However, with clear support around $190, that risk is somewhat mitigated and consolidation within the established trading range is the more likely near-term outcome. In that scenario, the stock could trade sideways until a new catalyst or technical trigger emerges. 
The 30-day exponential moving average (EMA) is rising and converging with price, reinforcing support at the $190 level. This EMA captures short-term trading activity, which currently looks constructive. If the market holds with EMA support, a swift move back toward the range top is possible. Technical indicators such as the stochastic and MACD suggest the market is approaching oversold conditions and that bearish momentum may be moderating — signs that a bottom could be near. RTX Buzzes Into Buy Zone Following Strong Q1 ReleaseRTX reported a strong Q1, with across-the-board strength driven by both commercial and defense-related demand. Net revenue of $22.1 billion rose nearly 9%, outpacing consensus by roughly 300 basis points, with Pratt & Whitney leading the gain. Pratt & Whitney grew 11%, Raytheon rose 10%, and Collins Aerospace increased 5%, all contributing to margin expansion. The result was 22% adjusted net income growth, 21% adjusted EPS growth, and a 65% jump in free cash flow. Guidance — not underlying fundamentals — was the headwind that triggered the post-release pullback. The company raised its outlook for revenue and earnings but still missed consensus expectations. A critical detail: backlog expanded to about $271 billion, equivalent to more than 10 quarters of revenue at the Q1 pace. That backlog suggests execution is the primary determinant between guidance and outperformance, and the company is focused on backlog management, improving throughput, and continued investment in R&D. The biggest risk for investors remains valuation. Trading above 28x earnings as of early Q2 2026, the stock sits at the upper end of its historical range and is pricing in strong growth. In that environment, execution is paramount — delays, missteps, or other execution issues will likely be reflected quickly in the share price. |
Post a Comment
Post a Comment